Senior insider sale
President and CEO at ALLOGENE THERAPEUTICS, INC. — senior position signals high conviction
$117.8K
47.76K shares
What this filing means
CHANG DAVID D plans to sell 47.76K shares of ALLOGENE THERAPEUTICS, INC. valued at approximately $117.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/17/2026ACC: 0001611024-26-000003
DirectorOfficer· President and CEO
Since Oct 2018
47.76K
Shares to sell
$117.8K
Approx. market value
47.76K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit award
Granted as part of issuer equity compensation plan
3/13/2026
47.76KTotal acquired47.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/13/2026 | Vesting of restricted stock unit award Granted as part of issuer equity compensation plan | 47.76K | — |
| Total | 47.76K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
47.76K
Market value
$117.8K
3/16/2026
Total
Units
47.76K
Value
$117.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/16/2026 | 47.76K | $117.8K | NASDAQ | Planned |
| Total | 47.76K | $117.8K | ||